Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
NeLM news service
Review: Management of stable coronary artery disease

Reference: Lancet 2010; 375: 763-772

Source: Lancet

Date published: 26/02/2010 15:52

Summary
by: Yuet Wan

In this review of stable coronary artery disease in the Lancet, the authors draws attention to the controversial issues in both management approaches, analyses the strengths and limitations of recent trials, and proposes a treatment algorithm that is applicable to daily clinical practice.

Abstract

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Related evidence
2.4 Beta-adrenoceptor blocking drugs
21/10/2011
Evening versus morning dosing regimen drug therapy for hypertension
24/08/2011
NICE issues updated clinical guideline on the management of hypertension (CG 127)
01/08/2011
NICE issues clinical guideline for the management of stable angina
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
05/02/2012
Pentoxifylline for intermittent claudication
17/01/2012
SMC does not recommend ranolazine (Ranexa®) as an add-on for stable angina
31/12/2011
Naftidrofuryl for dementia
2.9 Antiplatelet drugs
26/10/2011
NICE issues guidance on ticagrelor for the treatment of acute coronary syndromes (ACS) – TA 236
01/08/2011
NICE issues clinical guideline for the management of stable angina
15/06/2011
MTRAC review: Ticagrelor for the treatment of acute coronary syndromes
2.12 Lipid-regulating drugs
02/02/2012
Bezafibrate for primary biliary cirrhosis
19/01/2012
AWMSG issues Final Appraisal Recommendation on rosuvastatin (Crestor®)
11/10/2011
Scottish Medicines Consortium does not recommend rosuvastatin (Crestor®) for use in NHS Scotland for prevention of major cardiovascular events
Ischaemic heart disease
17/01/2012
SMC does not recommend ranolazine (Ranexa®) as an add-on for stable angina
26/10/2011
NICE issues guidance on ticagrelor for the treatment of acute coronary syndromes (ACS) – TA 236
26/10/2011
NICE issues clinical guideline on the management of hyperglycaemia in people with acute coronary syndromes (CG 130)
Related news
2.4 Beta-adrenoceptor blocking drugs
23/01/2012
Research suggests beta-blockers should be continued peri-operatively
16/01/2012
British Medical Journal features discussion of hypertension guidelines
12/01/2012
Case control study: Antihypertensive drugs and risk of incident gout among patients with hypertension
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
16/01/2012
British Medical Journal features discussion of hypertension guidelines
12/01/2012
Case control study: Antihypertensive drugs and risk of incident gout among patients with hypertension
16/12/2011
European CHMP recommends approval of license extension for ivabradine (Procoralan) as treatment of chronic heart failure (NYHA II to IV) and updates contra-indications
2.9 Antiplatelet drugs
09/02/2012
Dual or mono antiplatelet therapy for patients with acute ischaemic stroke or transient ischaemic attack: systematic review and meta-analysis
09/02/2012
NHS Choices assessment of press reports that 'economy class' DVT syndrome myth busted and new US guidelines on prevention of thrombosis
06/02/2012
Conference presentation: Clopidogrel addition to aspirin to prevent recurrent subcortical stroke of no benefit?
2.12 Lipid-regulating drugs
03/02/2012
Meta-analysis: Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death
02/02/2012
Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction
02/02/2012
Meta-analysis of statin effects in women versus men
Ischaemic heart disease
08/02/2012
Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor for acute MI in the UK
02/02/2012
Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction
26/01/2012
Determinants of the decline in mortality from acute myocardial infarction in England 2002 to 2010
Back